115 related articles for article (PubMed ID: 8354981)
1. Low-dose warfarin decreases coagulability without affecting prothrombin complex activity.
Holm J; Berntorp E; Carlsson R; Erhardt L
J Intern Med; 1993 Sep; 234(3):303-8. PubMed ID: 8354981
[TBL] [Abstract][Full Text] [Related]
2. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Holm J; Hillarp A; Erhardt L; Berntorp E
Thromb Res; 1999 Nov; 96(3):205-12. PubMed ID: 10588463
[TBL] [Abstract][Full Text] [Related]
3. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters.
Jerkeman A; Astermark J; Hedner U; Lethagen S; Olsson CG; Berntorp E
Thromb Res; 2000 Jun; 98(6):467-71. PubMed ID: 10899345
[TBL] [Abstract][Full Text] [Related]
4. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
5. Impact of rivaroxaban compared with warfarin on the coagulation status in Japanese patients with non-valvular atrial fibrillation: a preliminary analysis of the prothrombin fragment 1+2 levels.
Tajiri K; Sato A; Harunari T; Shimojo N; Yamaguchi I; Aonuma K
J Cardiol; 2015 Mar; 65(3):191-6. PubMed ID: 25192595
[TBL] [Abstract][Full Text] [Related]
6. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
7. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
Nilsson CU; Strandberg K; Reinstrup P
Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin fragment F 1 + 2 and oral anticoagulant therapy.
Li Z; Wu J; Mammen EF
Thromb Res; 1994 Sep; 75(6):601-7. PubMed ID: 7831679
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
Ascani A; Iorio A; Agnelli G
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Kamath S; Blann AD; Chin BS; Lip GY
J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin does not alter the anticoagulant activity of warfarin.
Stern R; Abel R; Gibson GL; Besserer J
J Clin Pharmacol; 1997 Nov; 37(11):1062-4. PubMed ID: 9506000
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
[TBL] [Abstract][Full Text] [Related]
13. Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose.
O'Reilly RA; Aggeler PM
Circulation; 1968 Jul; 38(1):169-77. PubMed ID: 11712286
[TBL] [Abstract][Full Text] [Related]
14. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
Choi Q; Kim JE; Hyun J; Han KS; Kim HK
Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].
Tomoda M; Yasaka M; Nakanishi Y; Takaguchi G; Nakamura A; Gotoh S; Kuwashiro T; Okada Y
Brain Nerve; 2017 May; 69(5):571-576. PubMed ID: 28479535
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
[TBL] [Abstract][Full Text] [Related]
17. Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients.
Kim SB; Lee SK; Park JS; Chi HS; Hong CD; Yang WS
Am J Kidney Dis; 2001 Feb; 37(2):343-7. PubMed ID: 11157376
[TBL] [Abstract][Full Text] [Related]
18. Circadian variations in laboratory measurements of coagulation assays after administration of rivaroxaban or warfarin in patients with nonvalvular atrial fibrillation.
Hitaka Y; Ogawa M; Zhang B; Goto S; Nagata Y; Morii J; Imaizumi S; Yasuda T; Matsumoto N; Matsunaga A; Saku K
J Cardiol; 2016 Dec; 68(6):529-535. PubMed ID: 26987789
[TBL] [Abstract][Full Text] [Related]
19. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Feinberg WM; Cornell ES; Nightingale SD; Pearce LA; Tracy RP; Hart RG; Bovill EG
Stroke; 1997 Jun; 28(6):1101-6. PubMed ID: 9183333
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in the anticoagulant effects of warfarin.
Hara K; Akiyama Y; Tajima T
Jpn J Pharmacol; 1994 Nov; 66(3):387-92. PubMed ID: 7869625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
